-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Werewolf Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2020 to Q3 2024.
- Werewolf Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $451K, a 53.3% decline year-over-year.
- Werewolf Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $4.09M, a 19.4% increase year-over-year.
- Werewolf Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $3.14M, a 39.6% increase from 2022.
- Werewolf Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $2.25M, a 2060% increase from 2021.
- Werewolf Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $104K, a 98.6% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)